These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The renin-angiotensin system and diabetic retinopathy. Kohner EM Klin Wochenschr; 1992; 69 Suppl 29():25-7. PubMed ID: 1614187 [TBL] [Abstract][Full Text] [Related]
3. New approaches to the treatment of diabetic retinopathy. Porta M; Maldari P; Mazzaglia F Diabetes Obes Metab; 2011 Sep; 13(9):784-90. PubMed ID: 21535345 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment. Andersen NH; Mogensen CE J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):146-52. PubMed ID: 11881115 [No Abstract] [Full Text] [Related]
5. The Renin-Angiotensin system and vascular disease in diabetes. Deinum J; Chaturvedi N Semin Vasc Med; 2002 May; 2(2):149-56. PubMed ID: 16222606 [TBL] [Abstract][Full Text] [Related]
6. RAAS in diabetic retinopathy: mechanisms and therapies. Li X; Fu YH; Tong XW; Zhang YT; Shan YY; Xu YX; Pu SD; Gao XY Arch Endocrinol Metab; 2024 Apr; 68():e230292. PubMed ID: 38652701 [TBL] [Abstract][Full Text] [Related]
7. Diabetes complications and the renin-angiotensin system. Perkins BA; Aiello LP; Krolewski AS N Engl J Med; 2009 Jul; 361(1):83-5. PubMed ID: 19571288 [No Abstract] [Full Text] [Related]
8. The therapeutic implications of renin-angiotensin system blockade in diabetic retinopathy. Jeganathan VS Curr Pharm Biotechnol; 2011 Mar; 12(3):392-5. PubMed ID: 20939795 [TBL] [Abstract][Full Text] [Related]
11. Modulation of the renin-angiotensin system and retinopathy. Chaturvedi N Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i29-31:discussion i50. PubMed ID: 10956318 [No Abstract] [Full Text] [Related]
12. [Anti-atherosclerotic action of ACE inhibitors. I. Inactivation of the renin-angiotensin system]. Stajszczyk M; Gmiński J Postepy Hig Med Dosw; 1996; 50(2):157-71. PubMed ID: 8848424 [TBL] [Abstract][Full Text] [Related]
13. The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study. Klein R; Moss SE; Sinaiko AR; Zinman B; Gardiner R; Suissa S; Donnelly SM; Kramer MS; Goodyer P; Strand T; Mauer M Ophthalmology; 2006 Dec; 113(12):2231-6. PubMed ID: 16996597 [TBL] [Abstract][Full Text] [Related]
14. Renal and retinal effects of enalapril and losartan in type 1 diabetes. Katavetin P; Katavetin P N Engl J Med; 2009 Oct; 361(14):1410-1; author reply 1411. PubMed ID: 19802919 [No Abstract] [Full Text] [Related]
15. Optimal inhibition of renin angiotensin system to salvage 'at risk' diabetic kidneys--emerging Indian evidence. Shah SN; Bansode BR; Kamath SA J Assoc Physicians India; 2004 Mar; 52():183-6. PubMed ID: 15636305 [No Abstract] [Full Text] [Related]
16. [Inhibition of angiotensin converting enzyme: a decade's experience]. Martínez Amenós A Med Clin (Barc); 1990 Jun; 95(4):143-6. PubMed ID: 2250536 [No Abstract] [Full Text] [Related]
17. Prospects for angiotensin receptor blockers in diabetic retinopathy. Sjølie AK Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S31-9. PubMed ID: 17321627 [TBL] [Abstract][Full Text] [Related]